Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
DESCRIPTION OF MUTATIONAL PROFILE IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES AT THE TIME OF LEUKEMIC PROGRESSION
13 októbra, 2020 5:56 pmAuthor(s): Begoña Pedrote, Jose Francisco Falantes, Estrella Carrillo, et al. Abstract: PF496 Session topic: 10. Myelodysplastic syndromes –...
SEVERE THROMBOCYTOPENIA AS A PREDICTOR OF SURVIVAL AND RESPONSE TO HYPOMETHYLATING AGENTS: DATA FROM A LATIN-AMERICAN COHORT
13 októbra, 2020 5:56 pmAuthor(s): Carolina Lazzarino, Marcelo Iastrebner, Jacqueline Gonzalez, et al. Abstract: PS1259 Session topic: 10. Myelodysplastic syndromes – Clinical...
MYELODYSPLASTICKÝ SYNDROM – VÝBĚR Z EDUKAČNÍCH SDĚLENÍ A POSTERŮ
13 októbra, 2020 5:56 pmPráce publikované formou edukačních sdělení 1. FACING THE CHALLENGE: NOVEL TREATMENT OPTIONS FOR PATIENTS WITH MYELODYSPLASTIC SYNDROMES Nové...
AXICABTAGENE CILOLEUCEL (AXI-CEL) IN PATIENTS WITH REFRACTORY LARGE B CELL LYMPHOMA: OUTCOMES BY PRIOR LINES OF THERAPY IN ZUMA-1
13 októbra, 2020 5:56 pmAuthor(s): Frederick L. Locke, Armin Ghobadi, Lazaros J. Lekakis, et al. Abstract: S801 Session topic: 21. Aggressive Non-Hodgkin...
AN UPDATED ANALYSIS OF JULIET, A GLOBAL PIVOTAL PHASE 2 TRIAL OF TISAGENLECLEUCEL IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
13 októbra, 2020 5:56 pmAuthor(s): Peter Borchmann, Constantine S. Tam, Ulrich Jäger Abstract: S799 Session topic: 21. Aggressive Non-Hodgkin lymphoma – Clinical...
RELEVANCE: PHASE III EFFICACY AND SAFETY STUDY OF LENALIDOMIDE PLUS RITUXIMAB (R2) VERSUS RITUXIMAB PLUS CHEMOTHERAPY, FOLLOWED BY RITUXIMAB, IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA
13 októbra, 2020 5:56 pmAuthor(s): Frank Morschhauser, Nathan H. Fowler, Pierre Feugier, et. al Abstract: S154 Session topic: 20. Indolent Non-Hodgkin lymphoma...
ADDING POLATUZUMAB VEDOTIN (POLA) TO BENDAMUSTINE AND RITUXIMAB (BR) TREATMENT IMPROVES SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL: RESULTS OF A PHASE 2 CLINICAL TRIAL
13 októbra, 2020 5:56 pmAuthor(s): Laurie H. Sehn, Manali Kamdar, Alex F. Herrera, et al. Abstract: S802 Session topic: 21. Aggressive Non-Hodgkin...
FINAL ANALYSIS OF THE AHL201 RANDOMIZED PHASE III LYSA STUDY COMPARING AN EARLY PET DRIVEN TREATMENT DE-ESCALATION TO A NOT PET-MONITORED STRATEGY IN PATIENTS WITH ADVANCED STAGES HODGKIN LYMPHOMA
13 októbra, 2020 5:56 pmAuthor(s): Olivier Casasnovas, Pauline Brice, Reda Bouabdallah, et. al Abstract: S110 Session topic: 17. Hodgkin lymphoma – Clinical...
PRETREATMENT VITAMIN D DEFICIENCY IS ASSOCIATED WITH LOWER PROGRESSION- -FREE AND OVERALL SURVIVAL IN PROSPECTIVELY TREATED HODGKIN LYMPHOMA
13 októbra, 2020 5:56 pmAuthor(s): Sven Borchmann, Helen Görgen, Stephanie Sasse, et al. Abstract: S111 Session topic: 17. Hodgkin lymphoma – Clinical...
Nedostatok vitamínu D a znížené prežívanie pacientov s Hodgkinovým lymfómom
13 októbra, 2020 5:55 pmAutori tejto práce testovali hypotézu, či znížená hladina vitamínu D znižuje prežívanie bez progresie (PFS) a celkové prežívanie (OS) pacientov s Hodgkinovým...